Key result
Cardiomyopathy has emerged as an important cause of morbidity and mortality in children with heart disease, following dramatic advances in the care of structural congenital heart disease.
Highlights that as outcomes for structural congenital heart disease improve, cardiomyopathy has emerged as a leading cause of morbidity and mortality in pediatric heart disease.
T he dramatic advances in the operative and perioperative care of children with major forms of congenital heart disease have resulted in excellent short-and medium-term outcomes for the most severe forms of heart disease, including those with so-called single-ventricle physiology.This represents one of the great advances in pediatrics over the last 3 decades.A corollary of these observations is that some of the worst outcomes for children with heart disease are now observed in those with cardiomyopathy (whether acquired or congenital).This fact has drawn focus on heart muscle disease as an important cause of morbidity and mortality in children.
No takes yet. Share an insight, caveat, or question.
Steven A. Webber (2008) conducted an editorial in New-Onset Heart Failure and Cardiomyopathy. Cardiomyopathy has emerged as an important cause of morbidity and mortality in children with heart disease, following dramatic advances in the care of structural congenital heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: